Liu, H., Wei, P., Zhang, Q., Chen, Z., Aviszus, K., Downing, W., . . . Zhang, G. (2021). 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro. Taylor & Francis Group.
Chicago Style CitationLiu, Haolin, et al. 501Y.V2 and 501Y.V3 Variants of SARS-CoV-2 Lose Binding to Bamlanivimab in Vitro. Taylor & Francis Group, 2021.
MLA CitationLiu, Haolin, et al. 501Y.V2 and 501Y.V3 Variants of SARS-CoV-2 Lose Binding to Bamlanivimab in Vitro. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.